MedTrace Logo

Immune Dysregulation in Children and Adults With Asthma

NCT00135681 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2016-01-15

No results posted yet for this study

Summary

To immunize both normal and asthmatic subjects with a neoantigen, keyhole limpet hemocyanin (KLH) and observe the type of antibody and T cell response that develops.

Conditions

Interventions

DRUG

nedocromil budesonide

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • University of New Mexico

    lead OTHER

Principal Investigators

  • Mark Schuyler (Subproject PI) · University of New Mexico

Study Design

Purpose
TREATMENT

Eligibility

Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1996-12-31
Completion
2001-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00135681 on ClinicalTrials.gov